Pharmacy has become a highly remunerated female-majority profession with a small gender earnings gap and low earnings dispersion relative to other occupations. Using extensive surveys of pharmacists for 2000, 2004, and 2009 as well as the U.S. Census of Population, American Community Surveys and the Current Population Surveys, we explore the gender earnings gap, penalty to part-time work, demographics of pharmacists relative to other college graduates and evolution of the profession during the last half century. We conclude that technological changes increasing the substitutability among pharmacists, the growth of pharmacy employment in retail chains and hospitals, and the related decline of independent pharmacies reduced the penalty to part-time work and have contributed to the narrow gender earnings gap in pharmacy. Our findings on earnings, hours of work and the part-time work wage penalty are more consistent with a shift in technology than a shift in demand preferences on the part of workers in a model of equalizing differences. The position of pharmacist is among the most egalitarian of all U.S. professions today.
The converging roles of men and women are among the grandest advances in society and the economy in the last century. These aspects of the grand gender convergence are figurative chapters in a history of gender roles. But what must the “last” chapter contain for there to be equality in the labor market? The answer may come as a surprise. The solution does not (necessarily) have to involve government intervention and it need not make men more responsible in the home (although that wouldn’t hurt). But it must involve changes in the labor market, in particular how jobs are structured and remunerated to enhance temporal flexibility. The gender gap in pay would be considerably reduced and might vanish altogether if firms did not have an incentive to disproportionately reward individuals who labored long hours and worked particular hours. Such change has taken off in various sectors, such as technology, science and health, but is less apparent in the corporate, financial and legal worlds.